Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Chubb
Julphar
Accenture
Federal Trade Commission
Citi
Boehringer Ingelheim
Fuji

Generated: April 25, 2018

DrugPatentWatch Database Preview

VALMID Drug Profile

« Back to Dashboard

When do Valmid patents expire, and when can generic versions of Valmid launch?

Valmid is a drug marketed by Dista and is included in one NDA.

The generic ingredient in VALMID is ethinamate. There is one drug master file entry for this compound. Additional details are available on the ethinamate profile page.
Drug patent expirations by year for VALMID
Synonyms for VALMID
(1-ethynylcyclohexyl) carbamate
[(1-ethynylcyclohexyl)oxy]methanimidic acid
1-Ethinylcyclohexyl carbamate
1-Ethinylcyclohexyl carbonate
1-Ethynylcyclohexanol carbamate
1-Ethynylcyclohexyl carbamate
1-ethynylcyclohexylcarbamate
126-52-3
72347-67-2
AC1L1FL5
Aethinyl-cyclohexyl-carbamat
Aethinyl-cyclohexyl-carbamat [German]
API0007809
BRN 1946056
C07832
Carbamate de L'ethinylcyclohexanol
Carbamate de l'ethinylcyclohexanol [French]
Carbamic acid, 1-ethynylcyclohexyl ester
CHEBI:4884
CHEMBL1576
CS-6642
CTK5J0565
Cyclohexanol, 1-ethynyl-, 1-carbamate
Cyclohexanol, 1-ethynyl-, carbamate
Cyclohexanol, carbamate
D00703
D0CK3G
DB01031
DEA No. 2545
DTXSID7023013
EINECS 204-789-4
Ethinamat
ethinamate
Ethinamate (JAN/INN)
Ethinamate [INN:BAN:JAN]
Ethinamate, analytical standard
Ethinamatum
Ethinamatum [INN-Latin]
Ethinimate
Ethynylcyclohexanolcarbamate
Ethynylcyclohexyl carbamate
Etinamate
Etinamato
Etinamato [INN-Spanish]
FCH3411278
GTPL7325
GXRZIMHKGDIBEW-UHFFFAOYSA-N
HSDB 3325
HY-101584
IAN371PP48
LS-57167
MFCD00063343
NSC 11538
NSC-11538
NSC-30282
NSC-31618
NSC-524623
NSC11538
NSC30282
NSC31618
NSC524623
OR043136
OR211310
SCHEMBL44635
UNII-IAN371PP48
USAF EL-42
valamid
Valamin
Valamin (TN)
Valaminetta
Valaminettae
Valaminetten
Valmid (TN)
Valmidate
Volamin
WLN: L6TJ AOVZ A1UU1
ZINC1385

US Patents and Regulatory Information for VALMID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista VALMID ethinamate CAPSULE;ORAL 009750-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Healthtrust
Cantor Fitzgerald
Queensland Health
Julphar
Federal Trade Commission
Daiichi Sankyo
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.